Article Listing - News briefs from Sanofi, Bayer, GlaxoSmithKline and Novartis

THE NEW EC REGULATORY ENVIRONMENT

20 April 1992

The main problem with the current procedures for registering pharmaceutical products within the member states of the European Community has...

ALBANIAN PHARMA ASSOCIATION

20 April 1992

Albania's Ministry of Health has approved the establishment of the Albanian Pharmaceutical Assoc-iation, reports the ATA news agency. The new...

IMMUNIZATION FORM CONFUSION IN USA

20 April 1992

A series of immunization information forms may be a source of confusion for many Americans seeking vaccinations for their children,...

BROKER UPGRADES SWISS DRUG MAJORS

20 April 1992

Following recent results from Switzerland's big three chemical/ pharmaceutical groups, Shearson Lehman Brothers' analysts have upgraded their forecasts for the...

PATENT EXTENSION SOUGHT BY UPJOHN

20 April 1992

US pharmaceutical firm Upjohn, which is seeking an extension of the patent term of its non-steroidal anti-inflammatory drug Ansaid (flurbiprofen),...

ROBERTS NCRC DEAL COMPLETE

20 April 1992

Roberts Pharmaceutical of the USA has completed the acquisition of the National Clinical Research Centers in Bethesda, USA (Marketletter April...

FURTHER CONTROVERSY SURROUNDS TAMOXIFEN

20 April 1992

ICI's breast cancer drug tamoxifen has been linked with five deaths from liver disease in the UK. But the Committee...

AHP DEAL OVER GROWTH HORMONE STIMULATORS

20 April 1992

American Home Products Corp has obtained an exclusive license from Japan's Kaken Pharma to manufacture and market products based on...

SIR ARNOLD BURGEN RETIRES

20 April 1992

Sir Arnold Burgen has retired as a non-executive director of Amersham International, UK.

ZAMBON LAUNCHES ANTAXONE IN SPAIN

20 April 1992

Laboratorios Zambon has launched the opioid receptor antagonist product Antaxone (naltrexone) onto the Spanish market as a treatment for individuals...

Showing 94451-94460 of 95582 articles